StockData
Alamar Biosciences, Inc. logo

Alamar Biosciences, Inc. (ALMR) stock

ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$26.48−2.20 (-7.67%)

Close on Nov 20, 2026Market cap $1.84BP/E –Yield –

Alamar Biosciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$15.20M–
Q2 FY2026Jun 30, 2026-$14.96M–
Q1 FY2026Mar 31, 2026-$20.95M–
Q3 FY2025Sep 30, 2025-$15.36M–
Q2 FY2025Jun 30, 2025-$12.64M–
Q1 FY2025Mar 31, 2025-$13.62M–

More Alamar Biosciences figures

See a number that looks wrong?